GEHC
Ge Healthcare Technology
NASDAQ · Health Care
$80.65
-1.66 (-2.02%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 19.53B | 18.82B | 15.42B | 15.42B | 13.77B |
| Net Income | 1.98B | 1.72B | 1.79B | 1.54B | 1.48B |
| EPS | — | — | — | — | — |
| Profit Margin | 10.1% | 9.6% | 11.6% | 10.0% | 10.8% |
| Rev Growth | +3.8% | +3.8% | +14.6% | -4.4% | +20.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 9.48B | 9.48B | 3.39B | 3.20B | 2.89B |
| Total Equity | 8.90B | 8.90B | 19.64B | 21.16B | 22.20B |
| D/E Ratio | 1.06 | 1.06 | 0.17 | 0.15 | 0.13 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 3.32B | 3.04B | 3.19B | 2.74B | 2.82B |
| Free Cash Flow | — | — | 1.78B | 1.88B | 1.51B |